We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JVA:NASDAQCoffee Holding Co., Inc. Analysis

Data as of 2026-06-12 - not real-time

$4.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Coffee Holding Co. trades at $4.20, sitting below its 20‑day (4.32) and 50‑day (4.43) SMAs while still above the 200‑day SMA (4.02), indicating short‑term weakness in a longer‑term neutral backdrop. The RSI of 42 and a bearish MACD histogram reinforce a modest downside bias, and the stock’s 30‑day volatility of over 43% combined with a beta above 1.1 suggest heightened price swings. Yet the DCF‑derived fair value of $8.20 places the current price at roughly half of intrinsic worth, and valuation multiples—PE 12.35, forward PE 10.5, PB 0.83, and price‑to‑sales 0.24—signal a clear undervaluation. The dividend yield of 1.87% with a modest payout ratio adds income support.
Fundamentally, the company posted 20% revenue growth, albeit on thin margins (gross 16.6%, operating 9.3%, profit 1.9%). Cash flow remains positive with $1.99M operating cash and $1.65M free cash, though net debt exceeds $2M, giving a debt‑to‑equity ratio near 17. The market cap of $24 M and low average trading volume imply limited liquidity, while the consumer‑defensive packaged‑foods sector offers moderate resilience. Together, these factors paint a picture of a small, undervalued player with upside potential if it can sustain growth and navigate its liquidity and debt constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above the technical support level
  • Bearish MACD and neutral RSI indicating limited upside
  • High short‑term volatility and modest liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation suggests ~95% upside
  • Strong revenue growth and positive cash flow
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamental undervaluation across multiple multiples
  • Potential recovery from historical drawdown
  • Stable dividend and low price‑to‑book supporting long‑run confidence

Key Metrics & Analysis

Financial Health

Revenue Growth20.00%
Profit Margin1.89%
P/E Ratio12.4
ROE6.77%
ROA4.59%
Debt/Equity16.78
P/B Ratio0.8
Op. Cash Flow$2.0M
Free Cash Flow$1.7M

Technical Analysis

TrendNeutral
RSI42.0
Support$4.16
Resistance$4.59
MA 20$4.32
MA 50$4.43
MA 200$4.02
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$8.20
GradeUndervalued
TypeBlend
Dividend Yield1.87%

Risk Assessment

Beta1.17
Volatility43.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.